Dr. Attallah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3900 Woodland Ave
Philadelphia, PA 19104
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2005
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1996 - 1999
- Wayne State University School of MedicineClass of 1996
Certifications & Licensure
- PA State Medical License 2008 - 2026
- MI State Medical License 1999 - 2009
- CA State Medical License 2000 - 2005
- IL State Medical License 1996 - 1999
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults Start of enrollment: 2003 Mar 01
Publications & Presentations
PubMed
- Persistently low glucose levels despite high-dose methylprednisolone in a woman with mixed connective tissue disease.Gustavo Cumbo-Nacheli, Raul Torres-Heisecke, Hamdee Attallah
European Journal of Internal Medicine. 2008-10-01 - 13 citationsEffects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial.Hamdee Attallah, Anne L. Friedlander, Matilde Nino-Murcia, Andrew R. Hoffman
Plos Clinical Trials. 2007-05-04 - 31 citationsVisceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.Hamdee Attallah, Anne L. Friedlander, Andrew R. Hoffman
Growth Hormone & IGF Research. 2006-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: